Heritas Capital announces US$60m first close of Heritas Growth Fund III to back Asian emerging champions driving sustainable Covid-19 recovery
- Pan-Asia Impact Fund to back high-growth emerging champions developing smart platforms that enhance access to affordable quality healthcare and education for sustainable post-Covid recovery, in line with UN Sustainable Development Goals (SDGs)
- Builds on successful track record of earlier Growth Funds which have deployed US$150 million to back emerging category leaders including omni-channel healthcare and education solutions, next generation therapeutics, and precision medicine
- With first close anchored by impact-conscious investors Tsao Family Office and IMC Group, Fund III will go beyond seeking commercial returns to align intentionality and track material impact metrics that are collinear to scaling business and impact goals at the same time
Heritas Capital announces the first close of its third private equity fund, Heritas Growth Fund III (Fund III), at US$60 million. The first close follows Heritas Capital’s announcement early this year its plans to launch a US$150 million Fund III as a Pan-Asia Impact Fund focusing on high impact sectors within Healthcare, Education and Technology for building back better post Covid-19. Fund III seeks to back 10-15 emerging Asian champions with innovative and impactful solutions aligned with select UN SDG Goals. Ticket sizes for each Fund III investment may range from US$5 million to US$20 million, targeting high growth businesses seeking Series B financing and beyond to advance their solutions at-scale.
The launch of Fund III builds on Heritas’ successful track record of earlier Growth Funds which have deployed US$150 million to back smart platform solutions such as omni-channel healthcare and education solutions, next generation therapeutics, and precision medicine. Heritas has achieved post-investment value creation by supporting founders and management teams in their growth journey, leveraging on Heritas’ domain expertise, industry networks, sound governance and sustainable ESG / impact practices. Examples of Heritas-backed category leaders which have shown strong traction and resilience notwithstanding Covid-19, and continue to serve their respective communities with purpose include Q&M Dental (dental chain, Singapore); Timberland Medical Centre (private hospital, Malaysia); Alodoktor (telehealth, Indonesia); MFine (telehealth, India); and BHL Education (K-12 education, Vietnam). The latest investment by Heritas Capital was its follow-on participation in the US$125 million Series C round of Hummingbird Bioscience announced in May 2021 through Fund II, having been an early backer since Series A and B rounds via its Heritas Venture Fund (HVF) since 2019.
Fund III is set up as the first sub-fund under Heritas-managed Variable Capital Company (VCC), a new corporate structure tailored for investment funds using Singapore as a base for fund management and domiciliation. As a Capital Markets Services License Holder regulated by the Monetary Authority of Singapore, Heritas values the operational flexibility, sound governance and tax advantages offered by VCC and will be evaluating additional impact-oriented sub-funds such as Venture Capital, SPACs and Development Impact Bonds in future.
With its first close anchored by impact-conscious investors Tsao Family Office and IMC Group, Fund III will go beyond seeking commercial returns to align intentionality and track material impact metrics that are collinear to scaling business and impact goals at the same time. Such impact considerations are integrated within Heritas’ investment processes and aligned with its thesis of achieving impactful change, centered mainly on shifting consciousness, enhancing access and quality, and catalyzing market development through collaboration.
“IMC Group’s mission is to serve humanity well-being while creating economic wealth. We are pleased to back Heritas’ launch of its Growth Fund III as an Impact Fund to facilitate the shift of consciousness in business to be in alignment with development of humanity in the new era of wellbeing,” said Mr Frederick Chavalit Tsao, Chairman of IMC Group.
“Tsao Family Office, representing one of Asia’s most enduring business families, with over a century of history, is pleased to support Heritas Growth Fund III, an impact fund investing in businesses contributing to the benefit of society,” said Bryan Goh, CEO of Tsao Family Office.
“The first close of Heritas Growth Fund III is timely as Covid-19 has widened existing inequalities and devastated lives and livelihood; but also offered the opportunity to reconstruct more sustainable growth paradigms. With the accelerated innovation and adoption of new technologies and business models, we see new investment opportunities to back high growth businesses across Asia delivering scalable access to affordable quality healthcare and education, in line with UN SDGs. We are thankful for the support of impact-conscious anchor investors Tsao Family Office and IMC Group, and look forward to collaborating with like-minded impact investors, founders and stakeholders to achieve sustainable commercial success as well as impact creation,” said Chik Wai Chiew, CEO and Executive Director at Heritas Capital.
About Heritas Capital
Heritas Capital is a Singapore-based private equity and venture capital investment firm that invests in fast-growing companies across the healthcare, education and technology sectors. Guided by its investment philosophy, “Invest with Purpose, Impact Across Generations”, Heritas Capital backs innovative companies to become emerging champions and drive inclusive growth that improves the lives of local communities while delivering sustainable returns to investors. Heritas Capital’s impact-in-action platform Heritas Cares is an initiative to raise awareness of unmet social needs and to catalyze positive impact to the community through partnerships with its portfolio companies for the benefit of the local communities in which it operates.